Tracking Fuchs' dystrophy progression and genetics in the UK
Part of Eyes & vision, Genetic & congenital clinical trials.
This study follows people with Fuchs' endothelial corneal dystrophy over time to see how the condition changes and how it relates to their genes. It aims to help doctors better predict and manage the disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with Fuchs' endothelial corneal dystrophy
- You are willing to attend study visits and have eye exams
- You are willing to provide a blood or saliva sample
- You can understand the study and give your permission to join
- You do not have other eye diseases or had corneal surgery
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a treatment for people with Fuchs’ dystrophy that affects the clear layer at the back of the cornea. It may help improve how clear your vision is after the cornea can no longer pump fluid out properly.
This Phase 3 trial compares outcomes from two cornea transplant procedures in people with FECD, a disease that makes the cornea swell and affect vision. It may help you and others by identifying which approach best supports clear vision and stable corneal thickness after surgery.
This trial tests a new way to perform a corneal transplant (DSAEK) using a laser to prepare the donor tissue. It may help people with Fuchs' dystrophy or certain types of corneal swelling, but not those with glaucoma, scarring, or other eye diseases.
This trial tests whether Glanatec (ripasudil) eye drops help patients with Fuchs endothelial dystrophy get better results from Descemet stripping surgery. It may help improve vision and reduce symptoms for people whose vision problems come mainly from the Fuchs changes in the cornea.
This trial tests a new treatment, EO2002, for people with corneal swelling that causes vision loss. It aims to offer an alternative to corneal transplant for those with conditions like Fuchs dystrophy or swelling after cataract surgery.
This study uses a special microscope (Brillouin microscopy) to measure how stiff or flexible the cornea is. It helps researchers understand corneas after certain surgeries or with specific corneal diseases, and compares them to healthy eyes.
Hear when a new Fuchs Dystrophy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.